{"result": "{\n    \"title\": \"Glutamina and Nutritional Support in Burn Patients\",\n    \"summary\": \"The community focuses on the critical role of glutamina (glutamine) in the nutritional management of severe burn patients and other critically ill individuals. Key entities include glutamina, grandes quemados (severe burn patients), and various clinical studies that explore its effects on recovery and immune function. The relationships among these entities highlight the importance of glutamina in enhancing nutritional support and improving clinical outcomes for vulnerable populations.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant implications of nutritional management in critically ill patients, particularly those with severe burns.\",\n    \"findings\": [\n        {\n            \"summary\": \"Glutamina's role in metabolic stress management\",\n            \"explanation\": \"Glutamina is recognized as a non-essential amino acid that becomes essential under conditions of metabolic stress, such as in critically ill patients. It serves as a vital energy source for enterocytes and immune cells, which is crucial for recovery in patients experiencing heightened nutritional needs. Research indicates that glutamina supplementation can lead to improved outcomes in various clinical scenarios, particularly in patients undergoing autologous transplants and those suffering from severe burns. Its administration is linked to better postoperative complication rates and enhanced immune function during critical illness [Data: Reports (587); Entities (2907, 4002, 2052); Relationships (4116, 4151, 4153)].\"\n        },\n        {\n            \"summary\": \"Nutritional needs of grandes quemados\",\n            \"explanation\": \"Patients classified as grandes quemados (severe burn patients) face significantly increased metabolic demands, necessitating specialized nutritional support. Enteral nutrition is often required to meet these heightened dietary requirements effectively. The relationship between glutamina and these patients is critical, as glutamina supplementation is recommended to support recovery and immune function during their treatment. This highlights the importance of tailored nutritional strategies in managing the health of burn patients [Data: Reports (587); Entities (4002, 2052); Relationships (3728, 4153)].\"\n        },\n        {\n            \"summary\": \"Glutamina's impact on immune function\",\n            \"explanation\": \"Glutamina plays a crucial role in supporting immune cell function, particularly during periods of stress such as illness or injury. It provides energy to immune cells, which is essential for their proper functioning and response to infections. Studies have shown that glutamina supplementation can enhance the recovery of neutrophils, a type of white blood cell vital for immune defense, particularly in patients undergoing hematopoietic cell transplantation. This relationship underscores the importance of glutamina in maintaining immune health in critically ill patients [Data: Reports (587); Entities (2033, 3000, 3020); Relationships (4157, 4133)].\"\n        },\n        {\n            \"summary\": \"Clinical studies on glutamina supplementation\",\n            \"explanation\": \"Numerous studies have investigated the effects of glutamina supplementation in various patient populations, particularly those undergoing hematopoietic cell transplantation and suffering from cancer. The evidence regarding its effectiveness is mixed, with some studies suggesting positive outcomes while others do not confirm significant advantages. Nonetheless, glutamina has been associated with improved recovery processes and reduced complications in specific clinical settings, indicating its potential benefits in nutritional management [Data: Reports (587); Entities (3003, 3004, 3006); Relationships (4132, 4138, 4140)].\"\n        },\n        {\n            \"summary\": \"Glutamina's role in oncology nutrition\",\n            \"explanation\": \"In the context of oncology, glutamina is highlighted as a preventive treatment for patients requiring nutritional support. It has been shown to improve outcomes in cancer patients, particularly those experiencing complications such as mucositis. The relationship between glutamina and oncology nutrition emphasizes its importance in managing the nutritional needs of patients undergoing chemotherapy and other treatments, where maintaining nutritional status is critical for recovery [Data: Reports (587); Entities (4002, 2052); Relationships (4126, 4127)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n----Reports-----\nid,full_content\r\n587,\"# Glutamina and Nutritional Support in Burn Patients\n\nThe community focuses on the role of glutamina (glutamine) in the nutritional management of patients, particularly those with severe burns and other critical conditions. Key entities include glutamina, grandes quemados (severe burn patients), and various studies related to its effects on recovery and immune function. The relationships highlight the importance of glutamina in enhancing nutritional support and improving clinical outcomes for these vulnerable populations.\n\n## Glutamina's role in metabolic stress management\n\nGlutamina is recognized as a non-essential amino acid that becomes essential under conditions of metabolic stress, such as in critically ill patients. It serves as a vital energy source for enterocytes and immune cells, which is crucial for recovery in patients experiencing heightened nutritional needs. Research indicates that glutamina supplementation can lead to improved outcomes in various clinical scenarios, particularly in patients undergoing autologous transplants and those suffering from severe burns. Its administration is linked to better postoperative complication rates and enhanced immune function during critical illness [Data: Entities (2033, 4002, 2052); Relationships (4116, 4151, 4153)].\n\n## Nutritional needs of grandes quemados\n\nPatients classified as grandes quemados (severe burn patients) face significantly increased metabolic demands, necessitating specialized nutritional support. Enteral nutrition is often required to meet these heightened dietary requirements effectively. The relationship between glutamina and these patients is critical, as glutamina supplementation is recommended to support recovery and immune function during their treatment. This highlights the importance of tailored nutritional strategies in managing the health of burn patients [Data: Entities (4002, 2052); Relationships (3728, 4153)].\n\n## Glutamina's impact on immune function\n\nGlutamina plays a crucial role in supporting immune cell function, particularly during periods of stress such as illness or injury. It provides energy to immune cells, which is essential for their proper functioning and response to infections. Studies have shown that glutamina supplementation can enhance the recovery of neutrophils, a type of white blood cell vital for immune defense, particularly in patients undergoing hematopoietic cell transplantation. This relationship underscores the importance of glutamina in maintaining immune health in critically ill patients [Data: Entities (2033, 3000, 3020); Relationships (4157, 4133)].\n\n## Clinical studies on glutamina supplementation\n\nNumerous studies have investigated the effects of glutamina supplementation in various patient populations, particularly those undergoing hematopoietic cell transplantation and suffering from cancer. The evidence regarding its effectiveness is mixed, with some studies suggesting positive outcomes while others do not confirm significant advantages. Nonetheless, glutamina has been associated with improved recovery processes and reduced complications in specific clinical settings, indicating its potential benefits in nutritional management [Data: Entities (3003, 3004, 3006); Relationships (4132, 4138, 4140)].\n\n## Glutamina's role in oncology nutrition\n\nIn the context of oncology, glutamina is highlighted as a preventive treatment for patients requiring nutritional support. It has been shown to improve outcomes in cancer patients, particularly those experiencing complications such as mucositis. The relationship between glutamina and oncology nutrition emphasizes its importance in managing the nutritional needs of patients undergoing chemotherapy and other treatments, where maintaining nutritional status is critical for recovery [Data: Entities (4002, 2052); Relationships (4126, 4127)].\"\r\n\n\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n2907,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,\"The \"\"TRASPLANTE DE CÉLULAS HEMATOLÓGICAS\"\" is a medical procedure that involves the transfer of hematopoietic stem cells to a patient, primarily aimed at treating various hematological diseases. This procedure is particularly relevant for patients suffering from certain types of cancer and blood disorders. It is considered a potentially curative treatment for a range of hematological conditions and some solid tumors. The process typically requires the administration of high doses of chemotherapy followed by the infusion of hematopoietic cells.\n\nAdditionally, the procedure necessitates specific nutritional support to aid in the recovery and overall health of the patient. Research has also been conducted on the effects of glutamine in the context of hematopoietic cell transplantation, although the results of these studies have been controversial. Overall, the \"\"TRASPLANTE DE CÉLULAS HEMATOLÓGICAS\"\" represents a critical intervention in the management of serious hematological diseases.\",18\r\n2255,MUCOSITIS,\"MUCOSITIS is a painful inflammation of the mucous membranes in the digestive tract, commonly occurring as a side effect of cancer treatments such as chemotherapy and radiation therapy. This condition is particularly prevalent in oncology patients, including those undergoing high-dose chemotherapy and patients receiving hematopoietic cell transplants. Mucositis can lead to significant complications, including inflammation and ulceration of the mucous membranes, which severely impacts the patient's ability to eat and maintain adequate nutritional intake.\n\nIn pediatric oncology patients, mucositis may require specific nutritional interventions, such as parenteral nutrition, to manage the nutritional needs effectively. The condition can also complicate the recovery process for transplant patients, making it essential to address the symptoms and provide appropriate care. Research has indicated that glutamine administration may help reduce the duration and severity of mucositis.\n\nOverall, mucositis is a serious complication that affects the quality of life for patients undergoing cancer treatment, necessitating careful management to alleviate pain and support nutritional intake.\",17\r\n429,CORTICOIDES,\"Corticosteroids, commonly referred to as corticoides, are a class of steroid hormones that play a significant role in regulating various bodily functions. They are utilized in the treatment of several medical conditions, including hyperaldosteronism, where they help reduce aldosterone production. In oncology, corticosteroids such as dexamethasone, prednisolone, and methylprednisolone are employed to improve appetite and alleviate nausea in cancer patients, although they are associated with a range of side effects.\n\nCorticosteroids are also important in the diagnosis and treatment of Cushing's disease, a condition characterized by excessive cortisol levels. Additionally, they serve as anti-inflammatory medications in managing complications following hematopoietic cell transplants and are used to treat graft-versus-host disease. In these contexts, corticoides can enhance the adverse effects of chemotherapy, including nausea and vomiting.\n\nFurthermore, corticosteroids can influence carbohydrate metabolism in transplant patients and are effective in reducing inflammation during allergic reactions. However, it is important to note that while they can mitigate symptoms, they do not provide a corrective treatment for the underlying conditions. Overall, corticoides are versatile medications with a wide range of applications in both inflammatory and hormonal disorders.\",9\r\n2951,ENFERMEDAD DE INJERTO CONTRA HUÉSPED (EICH),\"La enfermedad de injerto contra huésped es una complicación grave del trasplante de células hematopoyéticas, donde las células inmunitarias del donante atacan los tejidos del receptor.\",3\r\n2961,ENFERMEDAD VENOCLUSIVA HEPÁTICA,\"Enfermedad venoclusiva hepática es un conjunto de síntomas y signos hepáticos que afecta a pacientes postrasplante, con una incidencia del 20%.\",3\r\n2952,CISPLATINO,\"Cisplatino is a chemotherapy drug utilized in the treatment of various types of cancer. It is known to be effective in managing certain malignancies but is also associated with a range of side effects. Common adverse effects include hypomagnesemia, as well as nausea and vomiting, particularly in patients undergoing hematopoietic cell transplantation.\",2\r\n2908,ENFERMEDAD DE INJERTO CONTRA HUÉSPED,\"Graft-versus-host disease (GVHD), known in Spanish as \"\"Enfermedad de Injerto Contra Huésped\"\" (EICH), is a serious complication that can arise following hematopoietic cell transplantation, including stem cell transplants. This condition occurs when the transplanted cells, or graft, initiate an immune response against the recipient's body, leading to significant morbidity and mortality. The disease is characterized by the attack of the donated cells on the recipient's tissues, which can necessitate specific nutritional interventions to manage the condition effectively. Overall, GVHD represents a critical challenge in the context of hematopoietic cell transplants, highlighting the importance of monitoring and addressing this potential complication.\",6\r\n2955,TRASPLANTE DE CÉLULAS HEMATOPOYÉTICAS,\"El trasplante de células hematopoyéticas es un procedimiento médico que implica la transferencia de células madre hematopoyéticas para tratar diversas enfermedades, incluyendo cáncer y trastornos sanguíneos. Este procedimiento es utilizado para abordar condiciones graves y puede ser fundamental en el tratamiento de ciertos tipos de cáncer. Sin embargo, el trasplante de células hematopoyéticas también conlleva riesgos y posibles complicaciones, tales como la enfermedad venoclusiva hepática y alteraciones metabólicas. En resumen, este tratamiento es una opción terapéutica importante, pero debe ser considerado con precaución debido a sus posibles efectos adversos.\",5\r\n1817,ACETATO DE MEGESTROL,\"Acetato de Megestrol is an orexigenic medication primarily utilized to enhance caloric intake and promote weight gain in patients experiencing nutritional deficiencies. It is particularly effective in improving appetite and increasing weight in cancer patients. However, it is important to note that while Acetato de Megestrol aids in weight gain, it does not contribute to an increase in lean mass or improve survival rates among these patients.\",4\r\n2957,EICH CRÓNICA,\"La EICH crónica es una forma de la enfermedad que aparece después de 100 días del trasplante, manifestándose con infecciones recurrentes y afectaciones en múltiples órganos.\",3\r\n2999,METOTREXATO,\"Metotrexato is a chemotherapy agent and immune system suppressant that is utilized in the treatment of cancer and autoimmune diseases. It functions as a cytotoxic agent, meaning it can kill or inhibit the growth of cancer cells. Additionally, Metotrexato interacts pharmacokinetically with glutamine, which may enhance its intratumoral concentrations and therapeutic effects. This dual role in both cancer treatment and immune modulation underscores its significance in medical therapies.\",4\r\n1818,CIPROHEPTADINA,\"Ciproheptadina is a potent antagonist of histamine and serotonin, recognized for its orexigenic properties. It has been evaluated for its potential to enhance appetite and promote weight gain, particularly in advanced cancer patients. While it is noted to increase appetite in this demographic, its effectiveness in significantly improving weight is limited.\",2\r\n1387,ENFERMEDADES HEMATOLÓGICAS,\"Enfermedades hematológicas refer to conditions that affect the blood and the organs responsible for blood production. These diseases can lead to excessive production of uric acid as a result of high cellular turnover. Treatment options for hematological diseases may include hematological cell transplants, which can help address the underlying issues associated with these conditions.\",2\r\n2914,CITOSTÁTICOS,\"Los citostáticos son medicamentos utilizados en quimioterapia para detener el crecimiento de células cancerosas, y son parte del proceso de trasplante de células hematológicas.\",1\r\n2911,ENFERMEDAD VENOCLOSIVA,\"La enfermedad venoclusiva es una complicación que puede surgir tras un trasplante de células hematológicas, caracterizada por la obstrucción de las venas del hígado.\",1\r\n2915,INMUNOSUPRESIÓN,\"La inmunosupresión es un proceso que reduce la actividad del sistema inmunológico, y es un aspecto importante en el manejo de pacientes trasplantados para prevenir el rechazo del injerto.\",1\r\n3022,NUTRICIONAL SUPPORT,,2\r\n2954,MELFALÁN,El melfalán es un medicamento quimioterapéutico que se utiliza en el tratamiento de ciertos cánceres y puede causar efectos adversos como náuseas y vómitos en pacientes sometidos a trasplante de células hematológicas.,1\r\n2822,MIRTAPAZAPINA,\"Mirtazapina is a tetracyclic antidepressant that increases the release of norepinephrine and serotonin, showing improvement in appetite and quality of life in cancer patients.\",2\r\n2962,CICLOSPORINA,La ciclosporina es un medicamento utilizado en el tratamiento de la enfermedad injerto contra huésped (EICH) que puede causar alteraciones en el metabolismo lipídico.,1\r\n2823,ANABOLIZANTES,\"Anabolics are testosterone derivatives considered for therapeutic use in cancer patients to counteract muscle mass loss, though they are less effective than acetato de megestrol.\",1\r\n3533,METILDOPA,Metildopa is an antihypertensive medication used to treat high blood pressure.,1\r\n3555,ZIDOVIDINA,Zidovudina is an antiretroviral medication used to treat HIV/AIDS.,1\r\n2959,AUTOGÉNICO O SINGÉNICO,\"El trasplante autogénico o singénico es un tipo de trasplante donde el donante y el receptor son la misma persona, generalmente con menor incidencia de EICH.\",1\r\n3017,TUMORES SÓLIDOS,Tumores sólidos are solid tumors that can lead to complications and may require nutritional support during treatment.,1\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\r\n555,NUTRICIÓN PARENTERAL,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,La nutrición parenteral es un método de soporte nutricional que puede ser requerido en pacientes trasplantados que no pueden alimentarse adecuadamente.,268\r\n136,NUTRICIÓN ENTERAL,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,La nutrición enteral puede ser necesaria para pacientes que no pueden alcanzar sus necesidades nutricionales tras un trasplante de células hematológicas.,234\r\n4522,MUCOSITIS,NUTRICIÓN PEDIÁTRICA,NUTRICIÓN PEDIÁTRICA addresses the nutritional challenges faced by patients with MUCOSITIS,194\r\n3678,PACIENTES,MUCOSITIS,Los pacientes sometidos a trasplante de células hematológicas pueden desarrollar mucositis como una complicación del tratamiento.,147\r\n1690,CORTICOIDES,PACIENTES,Corticosteroids are commonly prescribed to patients with chronic respiratory diseases to manage inflammation,139\r\n3679,PACIENTES,ENFERMEDAD DE INJERTO CONTRA HUÉSPED (EICH),Los pacientes que reciben un trasplante de células hematológicas están en riesgo de desarrollar enfermedad de injerto contra huésped.,133\r\n3680,PACIENTES,ENFERMEDAD VENOCLUSIVA HEPÁTICA,Los pacientes sometidos a trasplante de células hematopoyéticas pueden desarrollar enfermedad venoclusiva hepática.,133\r\n3688,PACIENTES,CISPLATINO,\"Cisplatino is a chemotherapy drug that affects patients undergoing treatment, leading to potential nutritional deficiencies\",132\r\n1055,PACIENTE,ENFERMEDAD DE INJERTO CONTRA HUÉSPED,Patients who undergo hematopoietic cell transplantation are at risk of developing graft-versus-host disease,114\r\n802,NUTRICIÓN,MUCOSITIS,\"La mucositis puede causar una reducción en la ingesta nutricional, lo que hace necesario el soporte nutricional\",110\r\n4455,NUTRICIÓN EN ONCOLOGÍA,MUCOSITIS,\"NUTRICIÓN EN ONCOLOGÍA is significantly impacted by MUCOSITIS, a condition that complicates nutritional intake and management for oncology patients. MUCOSITIS requires specific nutritional strategies to address the challenges it presents, highlighting the importance of tailored nutritional management in the context of oncology care.\",72\r\n1693,CORTICOIDES,NUTRICIÓN EN ONCOLOGÍA,Nutrition in oncology involves the use of corticosteroids to manage symptoms like appetite loss and nausea in cancer patients.,64\r\n4475,NUTRICIÓN EN ONCOLOGÍA,TRASPLANTE DE CÉLULAS HEMATOPOYÉTICAS,Trasplante de células hematopoyéticas is a procedure that often requires careful nutritional management,60\r\n989,MALNUTRICIÓN,MUCOSITIS,Mucositis can exacerbate malnutrición by making it difficult for patients to consume adequate nutrition.,60\r\n3886,ACETATO DE MEGESTROL,NUTRICIÓN EN ONCOLOGÍA,Nutrition in oncology includes the use of acetato de megestrol as part of dietary strategies to improve the nutritional status of cancer patients.,59\r\n4474,NUTRICIÓN EN ONCOLOGÍA,EICH CRÓNICA,\"La nutrición en oncología es crucial para el manejo de pacientes con EICH crónica, donde se deben seguir dietas específicas para mantener el estado nutricional\",58\r\n4132,GLUTAMINA,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,\"GLUTAMINA is utilized in the context of hematopoietic cell transplantation, where it has been the subject of various studies assessing its potential benefits. The evidence regarding its effectiveness is mixed, indicating that while some studies suggest positive outcomes, others do not confirm significant advantages. Specifically, intravenous glutamine has been investigated in patients undergoing hematopoietic cell transplantation to evaluate its impact on mortality rates and recovery processes.\",57\r\n4514,MUCOSITIS,PACIENTE ONCOLÓGICO,\"Mucositis is a condition that can significantly impact the dietary intake of oncological patients. It is characterized by inflammation and ulceration of the mucous membranes, which can hinder these patients' ability to eat normally. As a result, individuals undergoing cancer treatment may experience difficulties in maintaining adequate nutrition due to the effects of mucositis.\",56\r\n4127,GLUTAMINA,MUCOSITIS,\"Glutamina has been studied as a potential treatment to alleviate the symptoms of mucositis in patients, particularly those undergoing hematopoietic cell transplantation. Research indicates that glutamina can reduce both the duration and severity of mucositis, making it a valuable therapeutic option for managing this condition in affected patients.\",56\r\n4130,GLUTAMINA,METOTREXATO,\"Glutamina can decrease the renal clearance of metotrexato, leading to higher exposure to the drug\",43\r\n4128,GLUTAMINA,ENFERMEDAD VENOCLUSIVA HEPÁTICA,La glutamina se ha recomendado para mejorar los síntomas de la enfermedad venoclusiva hepática en pacientes trasplantados.,42\r\n4904,HOSPITAL UNIVERSITARIO 12 DE OCTUBRE,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,The Hospital Universitario 12 de Octubre provides nutritional support for patients undergoing hematopoietic cell transplantation,39\r\n4516,MUCOSITIS,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,La mucositis es una complicación común que puede surgir durante el trasplante de células hematológicas debido a la quimioterapia y la radiación recibida por el paciente.,35\r\n4500,NUTRICIÓN EN CIRUGÍA DE TUMORES DE CABEZA Y CUELLO,MUCOSITIS,La mucositis es un efecto secundario que puede complicar la nutrición en pacientes post-cirugía,31\r\n2501,VALORACIÓN NUTRICIONAL,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,La valoración nutricional es un paso crucial antes y durante el trasplante de células hematológicas para asegurar el estado nutricional del paciente.,30\r\n4531,QUIMIOTERAPIA,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,\"La quimioterapia es parte del proceso de trasplante de células hematológicas, utilizada para preparar al paciente antes del trasplante.\",30\r\n4520,MUCOSITIS,BONE MARROW TRANSPLANT,\"Mucositis is a common complication following a bone marrow transplant, affecting the patient's ability to eat and necessitating nutritional support.\",28\r\n3768,FQ,ACETATO DE MEGESTROL,Acetato de Megestrol is used as a treatment to improve caloric intake in patients with cystic fibrosis,28\r\n1697,CORTICOIDES,ALERGIA ALIMENTARIA,Los corticoides pueden ser utilizados para manejar la inflamación en casos severos de alergia alimentaria,28\r\n1694,CORTICOIDES,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,Los corticoides pueden ser utilizados para manejar complicaciones en pacientes trasplantados de células hematológicas.,27\r\n4905,HOSPITAL UNIVERSITARIO 12 DE OCTUBRE,ENFERMEDAD DE INJERTO CONTRA HUÉSPED,The Hospital Universitario 12 de Octubre addresses graft-versus-host disease through specialized nutritional support,27\r\n4513,MUCOSITIS,PACIENTE NEOPLÁSICO,\"Mucositis is a side effect that can hinder the ability of paciente neoplásico to eat, leading to malnutrition.\",27\r\n4512,MUCOSITIS,HEAD AND NECK CANCER,Mucositis is a common complication in patients with head and neck cancer undergoing treatment,26\r\n3769,FQ,CIPROHEPTADINA,Ciproheptadina is evaluated for its potential to enhance appetite in patients with cystic fibrosis,26\r\n4915,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,ENFERMEDAD DE INJERTO CONTRA HUÉSPED,La enfermedad de injerto contra huésped es una complicación que puede surgir tras un trasplante de células hematológicas.,24\r\n4918,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,CÉLULAS HEMATOLÓGICAS,El trasplante de células hematológicas implica la infusión de células hematológicas para tratar enfermedades hematológicas.,24\r\n4515,MUCOSITIS,CELULAS HEMATOPOYETICAS,La mucositis es un efecto secundario común en pacientes que reciben quimioterapia y puede complicar la nutrición en el contexto de un trasplante.,23\r\n2731,ANTIBIÓTICOS,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,Los antibióticos son administrados para prevenir infecciones en pacientes que han recibido un trasplante de células hematológicas.,22\r\n4922,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,ENFERMEDAD DE INJERTO CONTRA HUÉSPED (EICH),La enfermedad de injerto contra huésped es una de las complicaciones más temidas que pueden ocurrir tras un trasplante de células hematológicas.,21\r\n3227,ENFERMEDADES HEMATOLÓGICAS,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,El trasplante de células hematológicas se utiliza como tratamiento para diversas enfermedades hematológicas.,20\r\n4917,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,APLASIA,La aplasia es un efecto adverso que puede ocurrir como resultado del trasplante de células hematológicas.,20\r\n4921,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,RIESGOS,Los riesgos asociados con el trasplante de células hematológicas incluyen complicaciones infecciosas y efectos adversos de la terapia.,20\r\n4919,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,CITOSTÁTICOS,Los citostáticos son utilizados en el tratamiento previo al trasplante de células hematológicas para eliminar células enfermas.,19\r\n4916,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,ENFERMEDAD VENOCLOSIVA,La enfermedad venoclusiva es otra complicación que puede ocurrir después de un trasplante de células hematológicas.,19\r\n4920,TRASPLANTE DE CÉLULAS HEMATOLÓGICAS,INMUNOSUPRESIÓN,La inmunosupresión es necesaria para prevenir el rechazo del injerto en el trasplante de células hematológicas.,19\r\n4517,MUCOSITIS,CISPLATINO,El cisplatino puede causar mucositis como efecto secundario en pacientes que reciben quimioterapia antes del trasplante de células hematológicas.,19\r\n4518,MUCOSITIS,CICLOFOSFAMIDA,La ciclofosfamida puede inducir mucositis en pacientes sometidos a trasplante de células hematológicas debido a sus efectos secundarios.,19\r\n4521,MUCOSITIS,NUTRICIONAL SUPPORT,Mucositis can lead to increased nutritional needs and complications requiring nutritional support,19\r\n4519,MUCOSITIS,MELFALÁN,El melfalán puede causar mucositis en pacientes que están en tratamiento de quimioterapia antes del trasplante de células hematológicas.,18\r\n1671,ENFERMEDAD DE CUSHING,CORTICOIDES,\"Los corticoides son relevantes en el tratamiento y diagnóstico de la enfermedad de Cushing, afectando la regulación de ACTH\",17\r\n1696,CORTICOIDES,TRASPLANTE DE CÉLULAS HEMATOPOYÉTICAS,Los corticoides pueden afectar el metabolismo de los carbohidratos en pacientes que han recibido un trasplante de células hematopoyéticas.,14\r\n2694,HIPERURICEMIA,ENFERMEDADES HEMATOLÓGICAS,\"Enfermedades hematológicas can lead to excessive uric acid production, contributing to hyperuricemia\",13\r\n1691,CORTICOIDES,ACETATO DE MEGESTROL,\"Both acetato de megestrol and corticosteroids are used to manage appetite and quality of life in cancer patients, but they have different mechanisms and side effects.\",13\r\n1695,CORTICOIDES,ENFERMEDAD DE INJERTO CONTRA HUÉSPED (EICH),Los corticoides se utilizan en el tratamiento de la enfermedad de injerto contra huésped para reducir la inflamación y los síntomas asociados.,12\r\n4923,ENFERMEDAD DE INJERTO CONTRA HUÉSPED,TRASPLANTE DE CÉLULAS HEMATOPOYÉTICAS,\"La EICH es una complicación que surge específicamente del trasplante de células hematopoyéticas, lo que la relaciona directamente con este procedimiento\",11\r\n1692,CORTICOIDES,MIRTAPAZAPINA,\"Mirtazapina and corticosteroids are both used to enhance the quality of life and manage symptoms in cancer patients, focusing on appetite and nausea.\",11\r\n4925,ENFERMEDAD DE INJERTO CONTRA HUÉSPED,EICH CRÓNICA,La EICH crónica es otra forma de la Enfermedad de Injerto Contra Huésped que se presenta en un periodo más tardío postrasplante,9\r\n4924,ENFERMEDAD DE INJERTO CONTRA HUÉSPED,EICH AGUDA,La EICH aguda es una forma específica de la Enfermedad de Injerto Contra Huésped que se presenta en un periodo temprano postrasplante,9\r\n4971,TRASPLANTE DE CÉLULAS HEMATOPOYÉTICAS,ENFERMEDAD VENOCLUSIVA HEPÁTICA,La enfermedad venoclusiva hepática es una complicación que puede surgir tras el trasplante de células hematopoyéticas.,8\r\n4972,TRASPLANTE DE CÉLULAS HEMATOPOYÉTICAS,CICLOSPORINA,\"La ciclosporina es utilizada en el tratamiento de EICH en pacientes trasplantados, lo que puede llevar a alteraciones metabólicas.\",6\r\n2071,TAMOXIFENO,METOTREXATO,\"Tamoxifeno and Metotrexato can interact with nutrient metabolism, particularly affecting vitamin levels\",6\r\n3885,ACETATO DE MEGESTROL,ANABOLIZANTES,Anabolics and acetato de megestrol are both considered for therapeutic use in cancer patients to address muscle mass loss and appetite issues.,5\r\n5009,METOTREXATO,METILDOPA,Both Metotrexato and Metildopa are medications that can affect nutrient absorption and metabolism,5\r\n5010,METOTREXATO,ZIDOVIDINA,Zidovudina and Metotrexato can both influence the metabolism of certain vitamins,5\r\n4973,EICH CRÓNICA,AUTOGÉNICO O SINGÉNICO,\"La EICH crónica puede tener una menor incidencia en trasplantes autogénicos o singénicos, donde el donante y receptor son la misma persona\",4\r\n3887,CIPROHEPTADINA,MIRTAPAZAPINA,\"Ciproheptadina and mirtazapina are both medications aimed at improving appetite in cancer patients, though they have different effects and side effects.\",4\r\n5019,TUMORES SÓLIDOS,NUTRICIONAL SUPPORT,Patients with tumores sólidos may require additional nutritional support due to pre-existing malnutrition,3\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}